Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 53.85% is in line with its 1-year average of 54.15%, around the middle of its 1-year range (45.82%–57.35%).
0.07% above its 12-month average of 53.81%.
Reported quarterly gross margin; no daily interpolation. Q1 FY2026 (2026-07-31): 55.16%.
GROSS MARGIN
53.85%
GROSS MARGIN AVG TTM
53.81%
GROSS MARGIN AVG 3Y
N/A
GROSS MARGIN AVG 5Y
N/A
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+0.07%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
40.32%
median of 765 covered companies
CURRENT VS SECTOR MEDIAN
+33.56%
vs the sector median at left
MiniMed Group, Inc. Common Stock
Market Cap
$5.51B
Gross Margin
53.85%
TTM Avg
53.81%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.32B
Gross Margin
95.85%
TTM Avg
94.37%
3Y Avg
93.84%
5Y Avg
94.07%
Market Cap
$5.68B
Gross Margin
-15.02%
TTM Avg
-3561.64%
3Y Avg
-7339.64%
5Y Avg
-5851.73%
Market Cap
$5.73B
Gross Margin
54.49%
TTM Avg
70.12%
3Y Avg
77.23%
5Y Avg
64.22%
Market Cap
$5.28B
Gross Margin
54.72%
TTM Avg
55.10%
3Y Avg
55.18%
5Y Avg
55.10%
Market Cap
$5.18B
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-37.83%
Market Cap
$5.19B
Gross Margin
-6537.01%
TTM Avg
-3376.01%
3Y Avg
-7968.48%
5Y Avg
-11525.78%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MiniMed Group, Inc. Common Stock (MMED) | $5.51B | 53.85% | 53.81% | N/A | N/A |
| RadNet, Inc. (RDNT)vs › | $5.54B | 9.70% | 9.04% | 10.84% | 11.30% |
| Doximity, Inc. (DOCS)vs › | $5.33B | 88.07% | 89.65% | 88.97% | 88.20% |
| PTC Therapeutics, Inc. (PTCT)vs › | $5.32B | 95.85% | 94.37% | 93.84% | 94.07% |
| CG Oncology Inc. (CGON)vs › | $5.68B | -15.02% | -3561.64% | -7339.64% | -5851.73% |
| Kiniksa Pharmaceuticals International, plc (KNSA)vs › | $5.73B | 54.49% | 70.12% | 77.23% | 64.22% |
| Sotera Health Company (SHC)vs › | $5.28B | 54.72% | 55.10% | 55.18% | 55.10% |
| Cogent Biosciences, Inc. (COGT)vs › | $5.18B | 0.00% | 0.00% | 0.00% | -37.83% |
| CRISPR Therapeutics AG (CRSP)vs › | $5.19B | -6537.01% | -3376.01% | -7968.48% | -11525.78% |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.11B | 0.00% | 0.00% | -67.67% | -188.00% |
Gross Margin
53.9%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-07-31 | 55.16% |
| 2026-04-24 | 57.35% |
| 2026-01-31 | 45.82% |
| 2025-10-31 | 56.91% |
| 2025-04-30 | 55.52% |
